NPI: 1053380196 · OCALA, FL 34471 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 4,003 | $681K |
| 2019 | 9,325 | $1.32M |
| 2020 | 9,118 | $1.23M |
| 2021 | 5,634 | $491K |
| 2022 | 2,121 | $183K |
| 2023 | 248 | $43K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 15,589 | 615 | $2.39M |
| 90945 | 5,442 | 195 | $361K | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 1,508 | 449 | $211K |
| 82728 | 1,163 | 874 | $140K | |
| A4657 | Syringe, with or without needle, each | 654 | 456 | $138K |
| 83540 | 1,153 | 865 | $137K | |
| 83550 | 1,154 | 866 | $136K | |
| 85041 | 1,026 | 731 | $108K | |
| 85048 | 1,027 | 731 | $107K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 368 | 278 | $53K |
| J1756 | Injection, iron sucrose, 1 mg | 402 | 257 | $52K |
| 83970 | 368 | 278 | $46K | |
| 82746 | 180 | 134 | $21K | |
| 82607 | 179 | 133 | $20K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 161 | 94 | $16K |
| 85045 | 60 | 43 | $8K | |
| 90674 | 15 | 14 | $5K |